Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency

NCT01259544 is registered in ClinicalTrials.gov with Meridian Bioscience, Inc. as lead sponsor.

NCT NCT01259544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01259544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency
Lead sponsor
Meridian Bioscience, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
March 31, 2009
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, healthy volunteers